Category: Regulatory/FDA

CHC_FDA-Regulatory Images2

01/27/2017

Draft Guidance Covers How to Keep Communications Consistent with FDA Labeling

CHC_FDA-Regulatory Images1

01/27/2017

FDA Issues Draft Guidance on Payor Communications

CHC_FDA-Regulatory Images1

01/04/2017

FDA Will Study Consumer and HCP Ability to Identify Deceptive Drug Promotion

01/03/2017

OPDP Cites Two Companies for YouTube Videos Featuring INDs

12/21/2016

Two December Warning Letters Bring 2016 Tally Up to Three

slide_FDA-Regulatory Images1

12/15/2016

OPDP Sends Two Letters Citing Major Statement Treatment in TV Ad Claims

CHC_FDA-Regulatory Images2

10/06/2016

CMS Clarifies Sunshine Act CME Exclusion

CHC_FDA-Regulatory Images1

10/03/2016

OPDP’s Abrams: Enforcement Still a Priority, Despite Decrease in Letters

CHC_FDA-Regulatory Images1

09/15/2016

OPDP’s Second Enforcement Letter in Two Weeks Targets Investigational Drug